文献速递主动脉疾病

分期杂交修复Crawford II型胸腹主动脉瘤改善结局与价值

Improved outcomes and value in staged hybrid extent II thoracoabdominal aortic aneurysm repair.
PubMed 文献 · J Vasc Surg · 2017-05-31

本研究基于单中心2005至2015年前瞻性数据库,比较分期杂交(近端TEVAR后择期远端开放)与开放修复Crawford II型胸腹主动脉瘤的结局与医疗价值。杂交组主要不良事件(MAE)发生率20.0% vs 48.9%(P=.01),总费用更高,但按质量/成本计算的医疗价值提高56%至178%。

要点

  • 分期杂交修复II型TAAA的MAE发生率20.0%,显著低于开放组的48.9%。
  • 杂交组开放手术阶段手术时间、术后住院天数和出血量均显著少于开放组。
  • 杂交组总费用更高,但医疗价值评分提高56%至178%。

核心结论

  • 分期杂交修复Crawford II型TAAA的MAE发生率为20.0%,较开放修复的48.9%相对降低超过50%。
  • 尽管总费用更高,分期杂交修复的医疗相关价值较开放修复提高56%至178%。

研究设计与样本

  • 单中心前瞻性数据库研究,纳入2005至2015年连续113例Crawford II型TAAA修复患者。
  • 其中25例(22.1%)接受分期杂交修复,两次手术中位间隔129天。

主要发现

  • 杂交组与开放组基线人口学和合并症无差异(P>.05)。
  • 杂交组开放手术阶段手术时间255 vs 306分钟(P=.01),术后住院10.1 vs 13.3天(P=.02),出血量1300 vs 2600 mL(P=.01)。
  • 杂交组急性肾损伤发生率更高(76.0% vs 51.1%;P=.03),但肾衰竭无差异(8.0% vs 4.5%;P=.84)。
  • 杂交组MAE发生率更低(20.0% vs 48.9%;P=.01),院内死亡率无差异(4.0% vs 3.4%;P=.89)。
  • 杂交组中位总费用更高($112,920 vs $72,037;P=.003),按均值成本价值提高56%,按中位成本提高178%。

临床怎么用

  • 对于复杂Crawford II型TAAA,分期杂交修复可作为开放修复的替代方案,以降低MAE风险。
  • 需权衡杂交修复较高的总费用与改善的临床结局及医疗价值。

局限性

  • 单中心回顾性分析前瞻性数据库,样本量有限(杂交组25例)。
  • 非随机设计,存在选择偏倚可能。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Complex Crawford extent II thoracoabdominal aortic aneurysms (TAAAs) can be treated in a hybrid manner with proximal thoracic endovascular aneurysm repair, followed by staged distal open thoracoabdominal repair. This study evaluated the outcomes and health care-associated value of this new method compared with traditional open repair over 10 years. METHODS: A prospectively collected database was used to identify all patients with an extent II TAAA undergoing repair at a single institution between 2005 and 2015. Patient characteristics, postoperative outcomes, and incidence of major adverse events (MAEs; renal failure, spinal cord ischemia, death) were compared. After adjusting for time since surgery, value was analyzed looking at quality (1/MAE) divided by cost (total health system cost). This was multiplied by a constant to set the value of open TAAA repair to 100. RESULTS: A total of 113 consecutive patients underwent extent II TAAA repairs, of whom 25 (22.1%) had a staged hybrid approach with a median of 129 days between procedures. No baseline differences in demographic or comorbidity variables existed between groups (P > .05). The hybrid group had shorter operative time (255 vs 306 minutes; P = .01), shorter postoperative length of stay (10.1 vs 13.3 days; P = .02), and reduced blood loss (1300 vs 2600 mL; P = .01) at the time of open operation. Despite higher rates of acute kidney injury in the hybrid group (76.0% vs 51.1%; P = .03), there was no difference in renal failure (8.0% vs 4.5%; P = .84). The incidence of MAEs was lower in the staged hybrid group (20.0% vs 48.9%; P = .01), without a difference in hospital mortality (4.0% vs 3.4%; P = .89). Median total cost was higher in the hybrid group ($112,920 vs $72,037; P = .003). Value was improved in the hybrid group by 56% using mean cost and 178% by median cost. CONCLUSIONS: The 20% MAE rate associated with staged hybrid repair of extent II TAAA was significantly decreased compared with open repair, with a relative reduction of >50%. Despite higher total hospital costs, staged hybrid repair had 56% to 178% higher health care-related value compared with standard open repair. In an era of increasing focus on costs and quality, staged hybrid repair of extensive TAAAs is associated with fewer complications than open TAAA repair, resulting in a good value investment from a resource utilization perspective.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Hawkins RB, Mehaffey JH, Narahari AK, et al. Improved outcomes and value in staged hybrid extent II thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2017. PMID: 28579290. doi:10.1016/j.jvs.2017.03.420

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。